Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Menopause. 2010 Sep–Oct;17(5):978–982. doi: 10.1097/gme.0b013e3181d674d6

Figure 2. Skin Blood Flow Results.

Figure 2

Mean (± standard deviation) peak increases in cutaneous vascular conductance from baseline during 13 hot flashes. While nitric oxide synthase inhibition (L-NAME) attenuated the magnitude of cutaneous vasodilation, prostaglandin synthesis inhibition did not alter cutaneous vasodilation during the flashes. * indicates significant difference from control (P < 0.001). ¥ indicates significant difference from Ketorolac (P < 0.004).